Skyla Approval History
FDA Approved: Yes (First approved January 9, 2013)
Brand name: Skyla
Generic name: levonorgestrel
Dosage form: Intrauterine System
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Birth Control
Skyla (levonorgestrel) is a progestin-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to three years.
Development History and FDA Approval Process for Skyla
|Jan 10, 2013||U.S. FDA Approves Bayer's Skyla (Levonorgestrel-Releasing Intrauterine System) 13.5 mg For Prevention Of Pregnancy For Up To Three Years|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.